Login

Join for Free!
61254 members
table of contents table of contents

Ophthalmology has a long history of successful conventional biomaterial applications including viscoelastics, …


');

Biology Articles » Bioengineering » Closer to nature: new biomaterials and tissue engineering in ophthalmology » References

References
- Closer to nature: new biomaterials and tissue engineering in ophthalmology



1. Strong AB. Polymeric materials. In: Strong AB, ed. Plastics: materials and processing. New Jersey: Prentice-Hall, 1996;21-92.
2. Van Wachem PB, Beugeling T, Feijen J, et al. The role of van der Vaals forces and hydrogen bonds in hydrophobic interactions between biopolymers and low energy surfaces. Interface Sci 1986;111:378-390.
3. Horbet TA. Proteins: structure, properties, and adsorption to surfaces. In: Rattner BD, Hoffmen AS, Schoen FJ, Lemons JF, eds. Biomaterials science. San Diego: Academic Press, 1996;133-141.
4. Gristina AG. Biomaterial-centred infection:microbial adhesion versus tissue integration. Science 1987;237:1588-1595
5. Schakenraad JM. Cells: their surfaces and interactions with materials. In: Rattner BD, Hoffmen AS, Schoen FJ, Lemons JF, eds. Biomaterials science. San Diego: Academic Press, 1996;141-147.
6. Strong AB, Stubley GD, Chang G, et al. Theoretical and experimental analysis of cellular adhesion to polymer surfaces. J Biomed Mater Res 1987;21:1039-1055
7. Tang L, Eaton JW. Inflammatory responses to biomaterials. Am J Clin Pathol 1995;103:466-471
8. Anderson JM. Inflammation, wound healing and the foreign body response. In: Rattner BD, Hoffmen AS, Schoen FJ, Lemons JF, eds. Biomaterials science. San Diego: Academic Press, 1996;165-173.
9. Tang L, Eaton JW. Fibrinogen mediates acute inflammatory responses to biomaterials. J Exp Med 1993;178:2147-2156
10. Tang L, Lucas AH, Eaton JW. Inflammatory responses to implanted biomaterials: role of surface-adsorbed immunoglobulin G. J Lab Clin Med 1993;122:292-300
11. Ratner BD. Correlation of material surface properties with biological responses. In: Rattner BD, Hoffmen AS, Schoen FJ, Lemons JF, eds. Biomaterials science. San Diego: Academic Press, 1996;445-450.
12. Gristina AG, Naylor PT. Implant associated infection. In: Rattner BD, Hoffmen AS, Schoen FJ, Lemons JF, eds. Biomaterials science. San Diego: Academic Press, 1996;205-214.
13. Willliams DF. Definitions in biomaterials. Amsterdam: Elsevier, 1987;67-68.
14. Hayward JA, Chapman D. Biomembrane surfaces as models for polymer design: the potential for haemocompatibility. Biomaterials 1984;5:135-142
15. Durrani A, Hayward JA, Chapman D. Biomembranes as models for polymer surfaces. Biomaterials 1986;7:121-125
16. Ishihara K, Ziats NP, Tierney BP, et al. Protein adsorption from human plasma is reduced on phospholipid polymers. J Biomed Mater Res 1991;25:1397-1407
17. Campbell EJ, O'Byrne V, Stratford PW, et al. Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. ASIAO J 1994;40:853-857.
18. Denyer SP, Lim KS, Wong L, et al. In vitro ocular compatibility of glaucoma filtration implant materials. (ARVO Suppl) Invest Ophthalmol Vis Sci 1998;39:5114.
19. Young G, Bowers R, Hall B, et al. Clinical comparison of Omafilcon A with four control materials. CLAO J 1997;23:249-258
20. Young G, Bowers R, Hall B, et al. Six month clinical evaluation of a biomimetic hydrogel contact lens. CLAO J 1997;23:226-236
21. Ishihara K, Oshida H, Yutaka E, et al. Haemocompatibility of human whole blood on polymers with a phospholipid polar group and its mechanism. J Biomed Mater Res 1992;26:1543-1552
22. Amon M, Menapace R. Cellular invasion on hydrogel and poly(methylmethacrylate) implants; an in vivo study. J Cataract Refract Surg 1991;17:774-779
23. Nagaoka S, Mori Y, Takiuchi H, et al. Interaction between BLLD components and hydrogels with polyoxyethylene chains. In: Shalaby SW, Hoffman A, Ratner BD, Horbet TA, eds. Polymers as biomaterials. New York: Plenum, 1984;361-374.
24. Kim SW. Nonthrombogenic treatments and strategies. In: Rattner BD, Hoffmen AS, Schoen FJ, Lemons JF, eds. Biomaterials science. San Diego: Academic Press, 1996;297-308.
25. Cao W, Hench LL. Bioactive materials. Ceramics Int 1996;22:493-507.
26. Ashworth JL, Rhatigan M, Sampath R, et al. The hydroxyapatite orbital implant:a prospective study. Eye 1996;10:29-37
27. Leon CR, Barraquer Jl Jr, Barraquer Jl Sr. Coralline hydroxyapatite keratoprosthesis in rabbits. J Refract Surg 1997;13:74-78
28. Dornhoffer JL. Hearing results with the Dornhoffer ossicular replacement prosthesis. Laryngoscope 1998;108:531-536
29. Zarnet JS, Darbar UR, Griffiths GS, et al. Particulate bioglass as a grafting material in the treatment of periodontal intrabony defects. J Clin Periodontol 1997;24:410-418
30. Tanner KE, Downes RN, Bonfield W. Clinical applications of hydroxyapatite reinforced materials. British Ceramic Trans 1994;93:104-107.
31. Elner SG, Elner VM. The integrin superfamily and the eye. Invest Ophthalmol Vis Sci 1996;37:696-701
32. Hynes RO. Integrins: versatility, modulation, and signalling. Cell 1992;69:11-25
33. Okamoto K, Matsuura T, Hosokawa R, et al. RGD peptides regulate the specific adhesion of osteoblasts to hydroxyapatite but not titanium. J Dental Res 1998;77:481-487
34. Garcia AJ, Ducheyne P, Boettiger D. Effect of surface reaction stage on fibronectin mediated adhesion of osteoblast like cells to bioactive glass. J Biomed Mater Res 1998;40:48-51
35. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Devel Biol 1995;11:549-599
36. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996;84:359-369
37. Lobel KD, Hench LL. In vitro adsorption and activity of enzymes on reaction layers of bioactive glass substrates. J Biomed Mater Res 1998;39:575-579
38. Harrison D, Johnson R, Tucci M, et al. Interaction of cells with UHMWPE impregnated with the bioactive peptides RGD, RGE, or poly-L-lysine. Biomed Sci Instrumentation 1997;34:41-46.
39. Dee KC, Andersen TT, Bizios R. Design and function of novel osteoblast-adhesive peptides for chemical modification of biomaterials. J Biomed Mater Res 1998;40:371-377
40. Langer RS, Vacanti JP. Tissue engineering. Science 1993;260:920-926
41. Langer RS, Vacanti JP. Tissue engineering: the challenges ahead. Sci Am 1999;280:62-65
42. Bell E, Ehrlich HP, Buttle DJ, et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981;211:1052-1054.
43. Yannas IV, Burke JF, Orgill DP, et al. Wound tissue can utilise a polymeric template to synthesise a functional extension of skin. Science 1982;215:174-176
44. Cao Y, Vacanti JP, Paige KT, et al. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue engineered cartilage in the shape of a human ear. Plast Reconstruct Surg 1997;100:297-302
45. Yannas IV, Orgill DP, Silver J, et al. Regeneration of sciatic nerve across a 15mm gap by use of a polymeric template. In: Gebeleim CG, ed. Advances in biomedical polymers. New York, 1987:1-9.
46. Davis MW, Vacanti JP. Towards the development of an implantable tissue engineered liver. Biomaterials 1996;17:365-372
47. Humes HD. Tissue engineering of a bioartificial kidney: a universal donor organ. Transplant Proc 1996;28:2032-2035
48. Okano T, Matsuda T. Tissue engineered skeletal muscle:preparation of highly dense, highly oriented hybrid muscle tissues. Cell Transplant 1998;7:71-82
49. Shinoka T, Ma PX, Shum-Tim D, et al. Tissue engineered heart valves: autologous valve leaflet replacement study in a lamb model. Circulation 1996;94:164-168.
50. L'Heureux N, Paquet S, Labbe R, et al. A completely biological tissue engineered human blood vessel. FASEB J 1998;12:47-56
51. Kane JB, Tompkins RG, Yarmush ML, et al. Burn dressings. In: Rattner BD, Hoffmen AS, Schoen FJ, Lemons JF, eds. Biomaterials science. San Diego: Academic Press, 1996;360-370.
52. Yannas IV. Natural materials. In: Rattner BD, Hoffmen AS, Schoen FJ, Lemons JF, eds. Biomaterials science. San Diego: Academic Press, 1996;84-94.
53. Naughton G, Mansbridge J, Gentzkow G. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. Artif Org 1997;21:1203-1210
54. Sittinger M, Bujia J, Rotter N, et al. Tissue engineering and autologous transplant fromation: practical approaches with resorbable biomaterials and new culture techniques. Biomaterials 1996;17:237-242
55. Germain L, Carrier P, Giasson M, et al. A new method for in vitro production of human reconstrcuted cornea by tissue engineering. (ARVO Suppl) Invest Ophthalmol Vis Sci 1999;40:1745
56. Cornelius EJ, Hubel A. Behaviour of corneal epithelial, endothelial, and stromal cells cultured on a three-dimensional matrix. (ARVO Suppl) Invest Ophthalmol Vis Sci 1998;39:3500.
57. Keller G, Snodgrass HR. Human embrionic stem cells: the future is now. Nat Med 1999;5:151-152
58. Bjornson CRR, Reitze RL, Reynolds BA, et al. Turning brain into blood: a haemopoetic fate adopted by adult neural stem cells in vivo. Science 1999;283:534-538
59. Lysaght MJ, Aebischer P. Encapsulated cells as therapy. Sci Am 1999;280:52-58.
60. Lysaght MJ, Aebischer P. Immunoisolation and cellular xenotransplantation. Xeno 1995;3:43-48.

rating: 4.35 from 17 votes | updated on: 23 Jan 2007 | views: 15509 |

Rate article:







excellent!bad…